Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.

Hu, Jiangfeng; Song, Chenlin; Duan, Bensong; Zhang, Xiaoyan; Li, Dongliang; Zhu, Liang; Gao, Hengjun

Hu, Jiangfeng; Song, Chenlin; Duan, Bensong; Zhang, Xiaoyan; Li, Dongliang; Zhu, Liang; Gao, Hengjun.

Afiliação

Hu J; Department of Gastroenterology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Song C; Division of Molecular Biology of the Cell II, German Cancer Research Center, DKFZ-ZMBH Alliance, Heidelberg, Germany.
Duan B; Department of Gastroenterology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Zhang X; Shanghai Engineering Center for Molecular Medicine, National Engineering Center for Biochip at Shanghai, Shanghai, China.
Li D; Department of Hepatobiliary Medicine, Fuzhou General Hospital of Nanjing Command, PLA, Fuzhou, China.
Zhu L; Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Gao H; National Engineering Center for Biochip at Shanghai, Shanghai, China.

Oncotarget ; 9(58): 31311, 2018 07 27.

Article em En | MEDLINE | ID: mdl-30131857

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article